Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vertex Pharmaceuticals

383.12
-3.9900-1.03%
Post-market: 383.600.4800+0.13%19:59 EDT
Volume:3.39M
Turnover:1.31B
Market Cap:98.23B
PE:27.23
High:389.46
Open:388.60
Low:382.60
Close:387.11
52wk High:519.88
52wk Low:362.50
Shares:256.39M
Float Shares:255.58M
Volume Ratio:2.09
T/O Rate:1.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.07
EPS(LYR):-2.0768
ROE:22.77%
ROA:13.09%
PB:5.72
PE(LYR):-184.48

Loading ...

Healthcare Stocks Are at an Historic Low and a Turnaround Is on the Horizon

Motley Fool
·
Yesterday

Vertex Minerals Issues New Shares to Bolster Financial Position

TIPRANKS
·
Sep 19

My Top Biotech Stock Picks And Portfolio Strategy For The Next 3-10 Years

Benzinga_recent_news
·
Sep 19

Vertex Pharmaceuticals Signs Reimbursement Deal With Italy for Casgevy Therapy

MT Newswires Live
·
Sep 18

Vertex Announces Casgevy® Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia and Sickle Cell Disease in Italy

THOMSON REUTERS
·
Sep 18

Vertex Minerals Highlights JORC Compliance in Latest Presentation

TIPRANKS
·
Sep 18

Vertex Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Sep 18

Shareholders have faith in loss-making Vertex (NASDAQ:VERX) as stock climbs 3.1% in past week, taking three-year gain to 87%

Simply Wall St.
·
Sep 17

2 Growth Stocks to Buy and Hold Forever

Motley Fool
·
Sep 17

Why This Biotech Company Could Be a Growth Stock Powerhouse

Motley Fool
·
Sep 17

Vortex Energy Advances Robinsons River Salt Project with Successful ANT Survey Completion

TIPRANKS
·
Sep 16

1 Reason Wall Street Is Obsessed With Vertex Pharmaceuticals

Motley Fool
·
Sep 15

Vertex Pharmaceuticals: Strong Buy Rating Backed by Promising Pipeline and Strategic Positioning

TIPRANKS
·
Sep 15

3 Absurdly Cheap Stocks to Buy for the Long Haul

Motley Fool
·
Sep 12

Evercore ISI Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Sep 12

BRIEF-Vertex Scientists Awarded The 2025 Lasker~Debakey Clinical Medical Research Award

Reuters
·
Sep 11

Vertex Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Sep 11

Vertex Scientists Awarded the 2025 Lasker~Debakey Clinical Medical Research Award for Pioneering Discoveries in Cystic Fibrosis

THOMSON REUTERS
·
Sep 11

Evercore ISI Adjusts PT on Vertex Pharmaceuticals to $475 From $510, Maintains Outperform Rating

MT Newswires Live
·
Sep 11

FDA Draft Guidance Boosts Vertex Pharmaceuticals’ Prospects for Non-Opioid Analgesics

TIPRANKS
·
Sep 11